_2020091018165303jzv.jpg "Decoding The World Of ETF")
My Account
Jan 25, 2021 02:55 PM IST Biocon’s revenue from the biologics business in Q3FY21 was Rs 769 Crore, a 11 percent increase year-on-year and 14 percent rise quarter-on-quarter, Biocon said in a BSE filing.
Jan 14, 2021 02:34 PM IST As vice chairs, Milind Pant, Kiran Mazumdar-Shaw and Edward Knight will work with USIBC president Nisha Biswal and the Council’s policy directors to elevate priorities in critical sectors and lead meetings between industry and government, the USIBC said in a statement.
Dec 10, 2020 06:49 PM IST Union Finance Minister Nirmala Sitharaman, Biocon Founder Kiran Mazumdar-Shaw and HCL Enterprise CEO Roshni Nadar Malhotra have found a mention in Forbes list of world's 100 most powerful women. The finance minister is ranked 41st on the list.
Dec 09, 2020 02:23 PM IST US Vice President-elect Kamala Harris, who became the first woman, first Black American and first Asian American to be elected vice president, is ranked third on the Forbes list.
Dec 03, 2020 05:46 PM IST With a net worth of Rs 54,850 crore, HCL Technologies Chairperson Roshni Nadar Malhotra is India's richest women in 2020, according to a study by Kotak Wealth and Hurun India. Biocon Chairperson Kiran Mazumdar-Shaw is the second-richest woman on the list, with a net worth of 36,600 crore, followed by Leena Gandhi Tewari, Chairperson of USV (Rs 21,340 crore). The cumulative wealth of the 100 women on the list is Rs 2.73 lakh crore, the study said. Here are India's richest women in 2020, as per the Kotak Wealth Hurun list:
Dec 03, 2020 03:36 PM IST Biocon Chairperson Kiran Mazumdar-Shaw is the second-richest woman on the list, with a net worth of 36,600 crore
Dec 03, 2020 01:23 PM IST To attain self-reliance, Indian companies still need to harness innovation through international partnerships and collaborations, Kiran Mazumdar-Shaw has said.
Nov 24, 2020 12:21 PM IST If the negotiations fructify— coming two weeks after the Goldman Sachs deal—it would mark the fourth successive investment in the Kiran Mazumdar Shaw-led Biocon unit in 2020.The last fundraise was struck at a valuation of $3.94 billion.
Oct 24, 2020 01:41 PM IST Shaw says vaccine candidates will first be approved for emergency use and full approval will come only after evaluating the durability of response.
Oct 08, 2020 07:45 PM IST The MoU was inked by Biocon Foundation Founder and Managing Trustee Kiran Mazumdar-Shaw and BMRCL Director Ajay Seth.
Oct 07, 2020 08:24 PM IST During my initial days, nobody was willing to give me a loan for my business as they did not understand biotechnology and therefore, did not understand my business idea, Mazumdar-Shaw said.
Aug 18, 2020 12:08 AM IST Biocon is one of the companies looking to create a vaccine to fight COVID-19
Aug 13, 2020 05:26 PM IST Referring to the COVID-19 vaccine developed by Russian state-backed Gamaleya National Research Center for Epidemiology and Microbiology, Kiran Mazumdar-Shaw said the world had not seen any data from the candidate’s human trials.
Jul 20, 2020 05:45 PM IST "If the Bharat Biotech vaccine, or Zydus Cadila vaccine starts showing good, promising results, we could also have it (vaccine) by the end of the year," Mazumdar-Shaw said.
Jun 05, 2020 07:39 AM IST Shaw, 67, founded Bangalore-based Biocon Limited in 1978 with just two employees and currently leads the company that is now worth close to Rs 50,000 crore by market-cap and employs more than 11,000 people.
Jun 02, 2020 03:58 PM IST Shaw added that the focus was needed more on flattening the death curve than the infection curve.
May 30, 2020 06:00 PM IST She was speaking in a webinar on 'Pharma and Healthcare's New Normal: Engaging With Customers in Uncertain Times; Business Model Post-COVID-19', organised by CorpGini.
May 28, 2020 04:00 PM IST "I think now there is anyway no point in extending the lockdown because of exodus of the migrant labour; they have basically gone to various parts of the country without any controls. So, now there is no point trying to extend lockdown any further. Now, its a question of quickly bringing under control any outbreak," Mazumdar-Shaw said.
May 18, 2020 11:28 AM IST Talking about the government's economic stimulus package, Biocon chief Kiran Mazumdar Shaw said that we have lost a big opportunity to create demand.
May 12, 2020 01:22 PM IST States with good primary healthcare system have fared better in containing the spread of COVID-19, biotechnology industry veteran Kiran Mazumdar- Shaw said
May 02, 2020 02:55 PM IST In an interview to PTI, the Executive Chairperson bio-pharmaceuticals major Biocon Ltd also suggested creating smaller red zones instead of classifying entire district as one so that economic activity picks up and supply chain is not cut-off.
Apr 18, 2020 08:45 PM IST "The seismic events unleashed by the COVID-19 pandemic will have a powerful impact on the world we live in, changing it in ways we had never imagined were possible. The economic damage is likely to be unprecedented," Mazumdar-Shaw said.
Apr 09, 2020 08:05 PM IST The Chairman and Managing Director of Biocon Ltd said she personally believes that schools and colleges - high risk areas where the virus can easily spread -- should be shut till June end.
Apr 09, 2020 12:28 PM IST Mazumdar-Shaw said testing by private labs will plummet, since they are conducting the tests at an upfront cost.
Apr 01, 2020 01:18 PM IST COVID-19 crisis has shown us that we have to focus on these very important healthcare areas. Infectious diseases have been neglected and ignored for too long, Mazumdar-Shaw pointed out.
